Nippon Kayaku Expands Generic Cancer Drug Business
This article was originally published in PharmAsia News
Executive Summary
Nippon Kayaku released financial results June 30 showing pharmaceutical sales increased 8.6 percent to ¥49.7 billion and profits were up 7.9 percent to ¥10.1 billion for fiscal year 2009